95 percent of clinical trial participants reported better sleep in four weeks BELFAST, Northern Ireland, Oct. 28, 2024 /PRNewswire/ -- Neurovalens, a global health-tech leader in neurotechnology, has ...

Neurovalens successfully secured 510(k) clearance from the FDA on October 27, 2023 for its Modius Sleep device with relation to treatment of insomnia and/or anxiety. The clearance was supported by ...

During CES 2025, Neurovalens showcased its Modius Sleep device, a smart medical headband which can help treat insomnia.

BELFAST, Northern Ireland, Feb. 24, 2025 /PRNewswire/ -- Neurovalens, a global leader in noninvasive neurostimulation technology, is making significant strides in addressing chronic insomnia among U.S ...

Belfast-based medtech firm Neurovalens has secured approval to sell its device for treating insomnia in the EU and UK. The company’s Modius technology uses low-level electrical signals to stimulate ...

A Belfast medical company has secured regulatory approval for its device to be used by US veterans to help them deal with symptoms associated with post-traumatic stress disorder (PTSD). Neurovalens, ...

Neurovalens Ltd raised £6 million (US$8 million) in an investment round for its non-invasive neurostimulation devices, which treat insomnia and manage anxiety. The company will use the funds to expand ...